Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Dayenne G. van Leeuwen
Observed names:
D G van Leeuwen,
Dayenne G van Leeuwen,
Dayenne van Leeuwen
Institution:
Baylor College of Medicine
Observed institutions:
Houston Methodist,
Memorial Sloan Kettering Cancer Center,
Baylor College of Medicine,
Texas Children's Hospital
ORCID:
0000-0002-4605-5416
Observed ORCID:
0000-0002-4605-5416
OpenAlex ID:
A5076576740
Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo
2018
·
Sarwish Rafiq
, Oladapo O Yeku
, et al.
·
Nature Biotechnology
·
880
Engineered Tumor-Targeted T Cells Mediate Enhanced Anti-Tumor Efficacy Both Directly and through Activation of the Endogenous Immune System
2018
·
Mauro P. Avanzi
, Oladapo Yeku
, et al.
·
Cell Reports
·
376
CD40 Ligand-Modified Chimeric Antigen Receptor T Cells Enhance Antitumor Function by Eliciting an Endogenous Antitumor Response
2019
·
Nicholas F. Kuhn
, Terence J. Purdon
, et al.
·
Cancer Cell
·
275
PDF
Enhancing Antitumor Efficacy of Chimeric Antigen Receptor T Cells Through Constitutive CD40L Expression
2015
·
Kevin J Curran
, Beatrijs A Seinstra
, et al.
·
Molecular Therapy
·
238
IL-12-secreting CD19-targeted cord blood-derived T cells for the immunotherapy of B-cell acute lymphoblastic leukemia
2014
·
H J Pegram
, T J Purdon
, et al.
·
Leukemia
·
171
Safety and tolerability of conditioning chemotherapy followed by CD19-targeted CAR T cells for relapsed/refractory CLL
2019
·
Mark B. Geyer
, Isabelle Rivière
, et al.
·
JCI Insight
·
106
PDF
Feasibility and preclinical efficacy of CD7-unedited CD7 CAR T cells for T cell malignancies
2022
·
Norihiro Watanabe
, Feiyan Mo
, et al.
·
Molecular Therapy
·
82
IL-18 Secreting CAR T Cells Enhance Cell Persistence, Induce Prolonged B Cell Aplasia and Eradicate CD19+ Tumor Cells without Need for Prior Conditioning
2016
·
Mauro P. Avanzi
, Dayenne G. van Leeuwen
, et al.
·
Blood
·
34
Chimeric antigen receptor-induced antigen loss protects CD5.CART cells from fratricide without compromising on-target cytotoxicity
2024
·
Royce Ma
, Mae Woods
, et al.
·
Cell Reports Medicine
·
25
Constitutive IL-7 signaling promotes CAR-NK cell survival in the solid tumor microenvironment but impairs tumor control
2025
·
Matthew Dysthe
, Ishwar Navin
, et al.
·
Journal for ImmunoTherapy of Cancer
·
12
PDF
Enhancing CAR T Cell Anti-Tumor Efficacy through Secreted Single Chain Variable Fragment (scFv) Immune Checkpoint Blockade
2017
·
Sarwish Rafiq
, Hollie J. Jackson
, et al.
·
Blood
·
7
Abstract 2568: CAR T cells secreting an immune checkpoint blockade scFv have enhanced anti-tumor efficacy
2018
·
Sarwish Rafiq
, Oladapo Yeku
, et al.
·
Cancer Research
Show more works
View as search
Works count:
12
Citation count:
2,206
H-index:
10
I10-index:
10
Year
Topic
Type